https://www.epmmagazine.com/topics/opgen/index.rss en-gb © Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved. Wed, 11 Aug 2021 09:10:00 -0000 Oliver Schacht Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR). https://www.epmmagazine.com/pharmaceutical-industry-insights/antibiotic-developments/improving-our-approach-to-fighting-amr/ https://www.epmmagazine.com/pharmaceutical-industry-insights/antibiotic-developments/improving-our-approach-to-fighting-amr/ Wed, 11 Aug 2021 09:10:00 -0000 Medicine.png Oliver Schacht Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance. https://www.epmmagazine.com/pharmaceutical-industry-insights/antibiotic-developments/the-state-of-bioinformatics-in-the-fight-against-amr/ https://www.epmmagazine.com/pharmaceutical-industry-insights/antibiotic-developments/the-state-of-bioinformatics-in-the-fight-against-amr/ Wed, 27 Jan 2021 14:15:00 -0000 Bioinformatics